CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C28204 | BRD-K81200901 | BRD-K81200901 | -- | -- | 2,2,3,3-Tetrafluoro-N-(2H-[1,2,4]triazol-3-yl)-propionamide | Details |
C28205 | BRD-K81202141 | BRD-K81202141 | -- | -- | -- | Details |
C28206 | BRD-K81206010 | BRD-K81206010 | -- | -- | -- | Details |
C28207 | BRD-K81209159 | herniarin | -- | -- | -- | Details |
C28208 | BRD-K81209512 | AG-494 | EGFR | EGFR inhibitor; Tyrosine kinase inhibitor | -- | Details |
C28209 | BRD-K81210389 | BRD-K81210389 | -- | -- | -- | Details |
C28210 | BRD-K81214387 | BRD-K81214387 | -- | -- | -- | Details |
C28211 | BRD-K81217407 | BRD-K81217407 | -- | -- | -- | Details |
C28212 | BRD-K81218586 | BRD-K81218586 | -- | -- | -- | Details |
C28213 | BRD-K81220870 | BRD-K81220870 | -- | -- | -- | Details |
C28214 | BRD-K81224183 | BRD-K81224183 | -- | -- | -- | Details |
C28215 | BRD-K81225797 | SCH-58261 | ADORA1; ADORA2A | Adenosine receptor antagonist | -- | Details |
C28216 | BRD-K81227048 | BRD-K81227048 | -- | -- | -- | Details |
C28217 | BRD-K81246784 | BRD-K81246784 | -- | -- | -- | Details |
C28218 | BRD-K81249055 | BRD-K81249055 | -- | -- | -- | Details |
C28219 | BRD-K81249836 | BRD-K81249836 | -- | -- | -- | Details |
C28220 | BRD-K81255325 | BG-1021 | -- | -- | -- | Details |
C28221 | BRD-K81258678 | triptolide | -- | -- | -- | Details |
C28222 | BRD-K81261525 | BRD-K81261525 | -- | -- | -- | Details |
C28223 | BRD-K81266242 | BRD-K81266242 | -- | -- | 1-(3-phenylpropanoyl)-4-(2-pyridinyl)piperazine | Details |
C28224 | BRD-K81272440 | dantrolene | RYR1 | Calcium channel blocker | -- | Details |
C28225 | BRD-K81275354 | naltriben-mesylate | -- | -- | -- | Details |
C28226 | BRD-K81277520 | BRD-K81277520 | -- | -- | -- | Details |
C28227 | BRD-K81281620 | BRD-K81281620 | -- | -- | -- | Details |
C28228 | BRD-K81284476 | BRD-K81284476 | -- | -- | -- | Details |
C28229 | BRD-K81288057 | BRD-K81288057 | -- | -- | -- | Details |
C28230 | BRD-K81288338 | BRD-K81288338 | -- | -- | -- | Details |
C28231 | BRD-K81291261 | BRD-K81291261 | -- | -- | -- | Details |
C28232 | BRD-K81293413 | BRD-K81293413 | -- | -- | -- | Details |
C28233 | BRD-K81300454 | BRD-K81300454 | -- | -- | -- | Details |
C28234 | BRD-K81311598 | BRD-K81311598 | -- | -- | -- | Details |
C28235 | BRD-K81312543 | BRD-K81312543 | -- | -- | -- | Details |
C28236 | BRD-K81313552 | BRD-K81313552 | -- | -- | -- | Details |
C28237 | BRD-K81313903 | BRD-K81313903 | -- | -- | -- | Details |
C28238 | BRD-K81314178 | BRD-K81314178 | -- | -- | -- | Details |
C28239 | BRD-K81314458 | BRD-K81314458 | -- | -- | -- | Details |
C28240 | BRD-K81316007 | 4-mu-8C | ERN1 | IRE1 inhibitor | -- | Details |
C28241 | BRD-K81318113 | BRD-K81318113 | -- | -- | -- | Details |
C28242 | BRD-K81322049 | BRD-K81322049 | -- | -- | -- | Details |
C28243 | BRD-K81331655 | BRD-K81331655 | -- | -- | -- | Details |
C28244 | BRD-K81332148 | BRD-K81332148 | -- | -- | -- | Details |
C28245 | BRD-K81332205 | BRD-K81332205 | -- | -- | -- | Details |
C28246 | BRD-K81332461 | maxacalcitol | VDR | Vitamin D receptor agonist | -- | Details |
C28247 | BRD-K81335188 | BRD-K81335188 | -- | -- | -- | Details |
C28248 | BRD-K81335284 | BRD-K81335284 | -- | -- | -- | Details |
C28249 | BRD-K81335986 | BRD-K81335986 | -- | -- | -- | Details |
C28250 | BRD-K81363924 | BRD-K81363924 | -- | -- | -- | Details |
C28251 | BRD-K81365078 | KU-C104122 | -- | -- | -- | Details |
C28252 | BRD-K81365479 | BRD-K81365479 | -- | -- | -- | Details |
C28253 | BRD-K81370109 | BRD-K81370109 | -- | -- | -- | Details |
C28254 | BRD-K81372179 | BRD-K81372179 | -- | -- | -- | Details |
C28255 | BRD-K81372870 | BRD-K81372870 | -- | -- | -- | Details |
C28256 | BRD-K81373254 | BRD-K81373254 | -- | -- | -- | Details |
C28257 | BRD-K81376179 | TCS-359 | FLT3 | FLT3 inhibitor | -- | Details |
C28258 | BRD-K81385845 | BRD-K81385845 | -- | -- | -- | Details |
C28259 | BRD-K81392055 | BRD-K81392055 | -- | -- | -- | Details |
C28260 | BRD-K81397638 | BRD-K81397638 | -- | -- | -- | Details |
C28261 | BRD-K81400584 | BRD-K81400584 | -- | -- | -- | Details |
C28262 | BRD-K81403739 | BRD-K81403739 | -- | -- | -- | Details |
C28263 | BRD-K81408913 | BRD-K81408913 | -- | -- | -- | Details |
C28264 | BRD-K81415316 | BRD-K81415316 | -- | -- | -- | Details |
C28265 | BRD-K81417919 | BRD-K81417919 | -- | -- | -- | Details |
C28266 | BRD-K81418486 | vorinostat | HDAC6; HDAC1; HDAC2; HDAC8; HDAC3 | HDAC inhibitor | -- | Details |
C28267 | BRD-K81424019 | BRD-K81424019 | -- | -- | -- | Details |
C28268 | BRD-K81438145 | BRD-K81438145 | -- | -- | -- | Details |
C28269 | BRD-K81438250 | BRD-K81438250 | -- | -- | -- | Details |
C28270 | BRD-K81439435 | BRD-K81439435 | -- | -- | -- | Details |
C28271 | BRD-K81440797 | BRD-K81440797 | -- | -- | -- | Details |
C28272 | BRD-K81441552 | BRD-K81441552 | -- | -- | -- | Details |
C28273 | BRD-K81447429 | BRD-K81447429 | -- | -- | -- | Details |
C28274 | BRD-K81450614 | BRD-K81450614 | -- | -- | -- | Details |
C28275 | BRD-K81457218 | BRD-K81457218 | -- | -- | -- | Details |
C28276 | BRD-K81458380 | CX-4945 | CSNK2A1; CSNK2A2 | Casein kinase inhibitor | -- | Details |
C28277 | BRD-K81461172 | BRD-K81461172 | -- | -- | -- | Details |
C28278 | BRD-K81463178 | BRD-K81463178 | -- | -- | -- | Details |
C28279 | BRD-K81464255 | BRD-K81464255 | -- | -- | -- | Details |
C28280 | BRD-K81465091 | BRD-K81465091 | -- | -- | -- | Details |
C28281 | BRD-K81468789 | BRD-K81468789 | -- | -- | -- | Details |
C28282 | BRD-K81469015 | BRD-K81469015 | -- | -- | -- | Details |
C28283 | BRD-K81471597 | BRD-K81471597 | -- | -- | -- | Details |
C28284 | BRD-K81473043 | tanespimycin | HSP90AA1 | HSP inhibitor | -- | Details |
C28285 | BRD-K81473089 | tacrine | ACHE; BCHE | Acetylcholinesterase inhibitor | -- | Details |
C28286 | BRD-K81475473 | BRD-K81475473 | -- | -- | -- | Details |
C28287 | BRD-K81476029 | BRD-K81476029 | -- | -- | -- | Details |
C28288 | BRD-K81491172 | BRD-K81491172 | -- | -- | -- | Details |
C28289 | BRD-K81496150 | BRD-K81496150 | -- | -- | -- | Details |
C28290 | BRD-K81500599 | BRD-K81500599 | -- | -- | -- | Details |
C28291 | BRD-K81501934 | BRD-K81501934 | -- | -- | -- | Details |
C28292 | BRD-K81510336 | BRD-K81510336 | -- | -- | -- | Details |
C28293 | BRD-K81514393 | BRD-K81514393 | -- | -- | -- | Details |
C28294 | BRD-K81515704 | BRD-K81515704 | -- | -- | -- | Details |
C28295 | BRD-K81521265 | dicyclohexylurea | -- | -- | -- | Details |
C28296 | BRD-K81522184 | BRD-K81522184 | -- | -- | -- | Details |
C28297 | BRD-K81522725 | BRD-K81522725 | -- | -- | -- | Details |
C28298 | BRD-K81524996 | BRD-K81524996 | -- | -- | -- | Details |
C28299 | BRD-K81527737 | BRD-K81527737 | -- | -- | -- | Details |
C28300 | BRD-K81528515 | nilotinib | ABL1; KIT; BCR | Abl kinase inhibitor | -- | Details |
C28301 | BRD-K81537454 | BRD-K81537454 | -- | -- | -- | Details |
C28302 | BRD-K81538844 | BRD-K81538844 | -- | -- | -- | Details |
C28303 | BRD-K81543095 | BRD-K81543095 | -- | -- | -- | Details |